To develop and market innovative products based on its patent-pending technologies utilizing Heliox and other gases for delivery of pharmaceuticals and CBD directly into the lungs.
https://purescientifictech.com/wp-content/uploads/2022/10/In-the-News-Featured-Image-1068-x-580.png
580
1068
support
https://purescientifictech.com/wp-content/uploads/2022/09/PST-HEAD-LOGO-V2-300x78.png
support2022-10-01 16:59:002022-11-10 20:27:51Pure Scientific Featured in MedTech Top Ten Startups
PST Heliox Inhaler smart technology may be integrated with a patient’s smartphone app via Bluetooth that provides data collection on dosage data, flow measurement, pressure, date, and time. The system is designed to provide secure data and metrics for patients, caregivers, and physicians leading to potentially better outcomes than traditional solutions.
In addition to that, the PST HELIOX INHALER utilizes a closed loop system with digital dosing controls that coordinate delivery of the active ingredient pharmaceutical/CBD compound and Heliox from a small cartridge in short measured doses with the peak of inspiration.
L. Michael Cutrer is a highly accomplished executive with extensive management and technical experience in the medical device field.
Irwin Olian is a highly successful entrepreneur with a strong legal and finance background. He is a creative innovator and proven business leader.
Over the past thirty years, he has leveraged his skills in strategic business planning, management, administration, finance, and law with creative thought and innovation to provide leadership to a large number of emerging companies.
Henry has over 20 years’ experience in financial and accounting matters for private and public companies, including familiarity with both Canadian and U.S. accounting standards.
Dr. Baldauf uses highly developed technologies such as Nitric Oxide and Heliox in the treatment of critically ill patients. She has extensive experience in the areas of mechanical ventilation and advanced airway management.
Dr. Martin Urban is a highly experienced radiologist with extensive management and entrepreneurial skills, whose 30-year career covers the full range of interventional radiology, computed tomography and ultrasound.
Philip Cacayorin, serving as Vice President – Technology, brings his exceptional advanced mathematics, physics and computer engineering skills to bear on development, fabrication and marketing of our new line of products utilizing the Company’s patent pending infusion technologies employing Heliox and helium as integral components of delivery systems for CBD and various pharmaceuticals directly into the lungs.
Lee has thirty-three years experience in sales and marketing, IT, management and business development with a strong investor relations background. His professional approach and focus will be communicating the PST story to the investment industry.
Citation – CBD Market Could Pull in $16 Billion by 2025, Says Study –This figure was far higher than what the Cowen analysts had expected. March 12, 2019. Forbes
